TPL
Company Details
Linkedin ID:
torrent-pharmaceuticals-ltd
Website:
Employees number:
11,324
Number of followers:
326,789
NAICS:
3254
Industry Type:
Homepage:
torrentpharma.com
IP Addresses:
0
Company ID:
TOR_9330091
Scan Status:
In-progress
Torrent Pharmaceuticals Ltd Company CyberSecurity Posture
torrentpharma.com
Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”
Torrent Pharmaceuticals Ltd A.I CyberSecurity Scoring
TPL Risk Score (AI oriented)Between 750 and 799
TPL
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
TPL Global Score (TPRM)XXXX
TPL
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
TPL Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
TPL Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for TPL
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for Torrent Pharmaceuticals Ltd in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Torrent Pharmaceuticals Ltd in 2025.
Incident Types TPL vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Torrent Pharmaceuticals Ltd in 2025.
Incident History — TPL (X = Date, Y = Severity)
TPL cyber incidents detection timeline including parent company and subsidiaries
TPL Company Subsidiaries
Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”
Loading...
TPL Similar Companies
Intas Pharmaceuticals
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Acc
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye ca
EMS is the leading pharmaceutical company in Brazil. Established since 45 years and with 100% national capital, the company has two industrial plants strategically placed in São Bernardo do Campo and Hortolândia, in the state of São Paulo. With a work based on daring, simplicity, excellence and res
Merck Group
This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trad
MENARINI Group
The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic
Parexel
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more th
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and
The Janssen Pharmaceutical Companies of Johnson & Johnson
At Janssen, we never stop working toward a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, and you can count on us to keep working tirelessly to make that future a reality for patients everywhere, by fighting sickness with science, improving ac
Merck KGaA, Darmstadt, Germany
We are Merck KGaA, Darmstadt, Germany and its global affiliates. We are a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to e
.png)
TPL CyberSecurity News
September 10, 2025 07:00 AM
Stocks to Watch: Torrent Pharma, RVNL, Eicher Motors and more
Torrent Pharma, Eicher Motors, Jupiter Wagons, and Tega Industries, which announced strategic acquisitions, GST benefit transfers,...
August 18, 2025 07:00 AM
Matt DeFrain rejoins MorganFranklin Cyber to head healthcare and life sciences
Matt DeFrain has rejoined MorganFranklin Cyber, a Charlotte, NC-based cybersecurity consulting and managed services firm,...
August 03, 2025 07:00 AM
Senores Pharma appoints Sanjay Moralwar as Head of IT
Ahmedabad: Senores Pharma has announced the appointment of Sanjay Moralwar as Head of Information Technology.\"Excited to welcome Mr. Sanjay...
October 17, 2022 07:00 AM
After Ipca Laboratories, pharma major Aarti Drugs hit by ransomware attack; data leaked on dark web
Leaked data (Aarti Drugs: 6 GB; Ipca Laboratories: 140 GB) includes employee records, formulation and research data, and financial and audit...
September 28, 2022 07:00 AM
Torrent Pharma to acquire Curatio Healthcare for ₹2,000 crore
Torrent Pharmaceuticals plans to buy dermatology company Curatio Health Care for ₹2,000 crore. With the acquisition, Torrent Pharma will add...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
TPL CyberSecurity History Information
Official Website of Torrent Pharmaceuticals Ltd
The official website of Torrent Pharmaceuticals Ltd is http://www.torrentpharma.com.
Torrent Pharmaceuticals Ltd’s AI-Generated Cybersecurity Score
According to Rankiteo, Torrent Pharmaceuticals Ltd’s AI-generated cybersecurity score is 788, reflecting their Fair security posture.
How many security badges does Torrent Pharmaceuticals Ltd’ have ?
According to Rankiteo, Torrent Pharmaceuticals Ltd currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Torrent Pharmaceuticals Ltd have SOC 2 Type 1 certification ?
According to Rankiteo, Torrent Pharmaceuticals Ltd is not certified under SOC 2 Type 1.
Does Torrent Pharmaceuticals Ltd have SOC 2 Type 2 certification ?
According to Rankiteo, Torrent Pharmaceuticals Ltd does not hold a SOC 2 Type 2 certification.
Does Torrent Pharmaceuticals Ltd comply with GDPR ?
According to Rankiteo, Torrent Pharmaceuticals Ltd is not listed as GDPR compliant.
Does Torrent Pharmaceuticals Ltd have PCI DSS certification ?
According to Rankiteo, Torrent Pharmaceuticals Ltd does not currently maintain PCI DSS compliance.
Does Torrent Pharmaceuticals Ltd comply with HIPAA ?
According to Rankiteo, Torrent Pharmaceuticals Ltd is not compliant with HIPAA regulations.
Does Torrent Pharmaceuticals Ltd have ISO 27001 certification ?
According to Rankiteo,Torrent Pharmaceuticals Ltd is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd employs approximately 11,324 people worldwide.
Subsidiaries Owned by Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd presently has no subsidiaries across any sectors.
Torrent Pharmaceuticals Ltd’s LinkedIn Followers
Torrent Pharmaceuticals Ltd’s official LinkedIn profile has approximately 326,789 followers.
NAICS Classification of Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Torrent Pharmaceuticals Ltd’s Presence on Crunchbase
No, Torrent Pharmaceuticals Ltd does not have a profile on Crunchbase.
Torrent Pharmaceuticals Ltd’s Presence on LinkedIn
Yes, Torrent Pharmaceuticals Ltd maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/torrent-pharmaceuticals-ltd.
Cybersecurity Incidents Involving Torrent Pharmaceuticals Ltd
As of December 22, 2025, Rankiteo reports that Torrent Pharmaceuticals Ltd has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Torrent Pharmaceuticals Ltd has an estimated 5,459 peer or competitor companies worldwide.
Torrent Pharmaceuticals Ltd CyberSecurity History Information
How many cyber incidents has Torrent Pharmaceuticals Ltd faced ?
Total Incidents: According to Rankiteo, Torrent Pharmaceuticals Ltd has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Torrent Pharmaceuticals Ltd ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
A vulnerability has been found in SeaCMS up to 13.3. The affected element is an unknown function of the file js/player/dmplayer/dmku/class/mysqli.class.php. Such manipulation of the argument page/limit leads to sql injection. The attack can be executed remotely. The exploit has been disclosed to the public and may be used.
Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in HappyDevs TempTool allows Stored XSS.This issue affects TempTool: from n/a through 1.3.1.
Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Tormorten WP Microdata allows Stored XSS.This issue affects WP Microdata: from n/a through 1.0.
Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description
Exposure of Sensitive System Information to an Unauthorized Control Sphere vulnerability in HappyDevs TempTool allows Retrieve Embedded Sensitive Data.This issue affects TempTool: from n/a through 1.3.1.
Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description
A vulnerability has been found in Tenda FH1201 1.2.0.14(408). Affected is the function sprintf of the file /goform/SetIpBind. Such manipulation of the argument page leads to stack-based buffer overflow. The attack may be performed from remote. The exploit has been disclosed to the public and may be used.
Risk Information
cvss2
Base: 9.0
Severity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
cvss4
Base: 7.4
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
- https://github.com/z472421519/BinaryAudit/blob/main/PoC/BOF/Tenda_FH1201/SetIpBind/SetIpBind.md
- https://github.com/z472421519/BinaryAudit/blob/main/PoC/BOF/Tenda_FH1201/SetIpBind/SetIpBind.md#reproduce
- https://vuldb.com/?ctiid.337689
- https://vuldb.com/?id.337689
- https://vuldb.com/?submit.719154
- https://www.tenda.com.cn/
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=torrent-pharmaceuticals-ltd' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
